Celiac Disease and Food Intolerance are increasingly recognized as major contributors to gastrointestinal disorders worldwide. This dedicated track at the Global Gastroenterology, Liver Diseases & Hepatology Conference & Industry Expo brings together leading clinicians, researchers, dietitians, and industry innovators to explore diagnosis, management, and emerging therapies for gluten-related disorders and food sensitivities.
Participants will gain insights into genetic and immunological mechanisms, advanced diagnostics, personalized nutrition strategies, gut microbiome interventions, and patient-centered care approaches. The track also emphasizes innovation, investment, and industry collaborations to accelerate the development of new therapies, functional foods, and technology-driven management solutions.
Through expert lectures, interactive workshops, case discussions, and networking opportunities, attendees will be equipped with the latest knowledge and tools to enhance clinical practice, foster collaboration, and advance research in the field of celiac disease and food intolerance.
Sub Topics: Celiac Disease, Gluten Sensitivity, Non-Celiac Gluten Sensitivity, Food Intolerance, Wheat Allergy, Lactose Intolerance, FODMAP Diet, Autoimmune Disorders, Gluten-Free Diet, Nutritional Therapy, Gut Microbiome, Pediatric Celiac, Adult Celiac, Diagnostic Testing, Serology, Endoscopy, Histology, Genetic Risk, HLA Typing, Intestinal Permeability, Malabsorption, Nutrient Deficiency, Anemia, Osteoporosis, Dermatitis Herpetiformis, Gastrointestinal Symptoms, Diarrhea, Constipation, Bloating, Abdominal Pain, Weight Loss, Fatigue, Autoimmune Thyroid, Type 1 Diabetes, Irritable Bowel Syndrome, Food Elimination Diet, Functional Foods, Enzyme Therapy, Probiotics, Prebiotics, Personalized Nutrition, Clinical Trials, Emerging Therapies, Patient Education, Telehealth, Digital Health Solutions, Investment Opportunities, Industry Partnerships, Research Collaboration, Innovation, Global Awareness, Healthcare Technology, Nutraceuticals
Keynote Points:
High global prevalence of H. pylori infection
Demand for accurate non-invasive and endoscopy-based diagnostics
Growth in combination therapies and resistance-guided treatment protocols
Integration of test–treat–confirm eradication models
Opportunities for patient adherence, monitoring, and digital follow-up tools
Collaboration with clinics, hospitals, and laboratory networks
Preventive focus to reduce ulcer recurrence and gastric cancer risk
Benefits:
Large, recurring patient base requiring diagnosis, treatment, and follow-up
Strong ROI through bundled diagnostics and treatment pathways
Predictable revenue via standardized management protocols
Differentiation through evidence-based and guideline-driven care models
Support for preventive healthcare and cancer-risk reduction initiatives
Scalable business opportunities across clinical, diagnostic, and digital platforms
WhatsApp: https://wa.me/+971551792927
Email: info-ucg@utilitarianconferences.com